Novartis Vaccines and Diagnostics Inc vs Wyeth et al, No. 2:08-cv-00067 (E.D. Tex. Mar. 31, 2010)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Pending before the Court is Defendants Wyeth and Wyeth Pharmaceuticals Inc.’s (collectively “Wyeth”) Motion to Transfer Venue to the Northern District of California. [Dkt. No. 66] After consideri ng the parties’ arguments and the app licable law, the Court is of the opinion that Wyeth’s motion should be DENIED. I. Background Plaintiff Novartis Vaccines and Diagnostics, Inc. (“Novartis”) filed this lawsuit on February 15, 2008, asserting infringement of U.S. Patent Nos.